Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 ir@digimedical.com www.digimedical.com
digiMedical Solutions, Inc.(TM) Launches New Prescription Re-Authorization Services Website
| Source: digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - April 22, 2009) - digiMedical Solutions, Inc.™ (PINKSHEETS : DGMS ) today announced the Company has launched a new website that will be
the focal point of the services offered by digiMedical's product
digiReAuth™.
digiReAuth™ provides doctors' offices and clinics with a digital
prescription re-authorization call center and refill system. The call
center intercepts and manages calls to doctors' offices and clinics from
patients and pharmacists seeking a re-authorization of a prescription. The
digiReAuth™ system and services is a quick and cost-effective process
that relieves the doctor's office or clinic of answering potentially
thousands of phone calls per month related to prescriptions handling.
Doctors' offices and clinics currently spend, on average, $5-$7 per
re-authorization call that they handle. digiReAuth™ provides a
significant cost savings for each of the doctors' offices and clinics that
have implemented these services. digiReAuth™ can be implemented quickly
with little or no impact on the clinic or office. For more information on
digiReAuth™ system and services, please visit www.digiReAuth.com.
To be added to digiMedical's corporate e-mail list to receive company
updates, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.™ (www.digiMedical.com)
digiMedical Solutions, Inc.™ is a pharmacy and medical technology company
focused on developing next generation, digital medical technology with an
emphasis on digital prescriptions (d-Prescriptions) that closely align the
doctor, pharmacist and patient. The company's planned growth will come from
three channels: direct marketing of the company's wireless based
d-prescription technology to physicians, direct marketing of the company's
digital call center services for refills and reauthorization and partnering
with independent pharmacy chains to focus sales with the technology suite.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission.